Clinical Trial Update: 18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

View source ↗

Summary

The update reports that the PSMA-targeted imaging agent 18F-DCFPyL used with PET/MRI to detect regional nodal and distant metastases in intermediate- to high-ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: Stanford University | Conditions: Prostate Cancer | Status: APPROVED_FOR_MARKETING